Blood protein may flag liver cancer spread risk after colon surgery
NCT ID NCT07177742
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at a protein called PRDX1 found in tiny particles (exosomes) in blood taken from the surgical specimen of colorectal cancer patients. The goal is to see if higher levels of this protein can predict which patients will develop liver metastasis after surgery. Researchers will follow 260 patients over time to track liver metastasis and local recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a new way to identify colorectal cancer patients at high risk for liver metastasis after surgery, allowing for earlier monitoring or treatment.
What could go wrong
This is an early observational study, not a treatment trial. It only looks for a link between a protein and metastasis; it does not test any intervention. The results may not lead to a reliable test or change in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Tongji Hospital, Hepatobilliary Surgery Center, Tongji University
RECRUITINGShanghai, Shanghai Municipality, 200065, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact